Comparative outcomes of nab-paclitaxel and paclitaxel in platinum-resistant ovarian cancer (COMPASS)
作者
Mark S. Shahin,Raina Mathur,Anju Parthan,Prakirthi Yerram,Amanda Kesner-Hays,Rachel Myers,Iulia Cristina Tudor,Darin Dobler,Adrian M. Jubb,Robert L. Coleman
Nab-paclitaxel demonstrated comparable effectiveness to paclitaxel with a lower rate of peripheral neuropathy, suggesting that nab-paclitaxel is an effective treatment option and a relevant comparator for clinical trials of patients with PROC.
PDF的下载单位、IP信息已删除
(2025-6-4)
Kao
大力的冬萱
Copyright
liuzhuohao
cdercder
行走的荷尔蒙
ale
Nole
OK
认真的不评
arniu2008
Avalonx
昏睡的蟠桃
Astraeus
Oracle
sanvva
sagitar
初景
学术文献互助
无情的聪健
皖公网安备34019202002308
